002198 嘉应制药
已收盘 11-22 15:00:00
资讯
新帖
简况
嘉应制药(002198)11月8日股东户数2.77万户,较上期增加19.68%
证券之星 · 11-18
嘉应制药(002198)11月8日股东户数2.77万户,较上期增加19.68%
嘉应制药(002198)11月15日主力资金净买入679.68万元
证券之星 · 11-18
嘉应制药(002198)11月15日主力资金净买入679.68万元
11月14日嘉应制药发布公告,其股东减持507.5万股
证券之星 · 11-14
11月14日嘉应制药发布公告,其股东减持507.5万股
嘉应制药(002198.SZ)主要股东东方证券完成减持1%股份
智通财经网 · 11-14
嘉应制药(002198.SZ)主要股东东方证券完成减持1%股份
嘉应制药:股东养天和大药房质押约3552.57万股 占公司总股本比例7%
中国财富通 · 11-14
嘉应制药:股东养天和大药房质押约3552.57万股 占公司总股本比例7%
嘉应制药(002198)股东养天和大药房股份有限公司质押3552.57万股,占总股本7%
证券之星 · 11-14
嘉应制药(002198)股东养天和大药房股份有限公司质押3552.57万股,占总股本7%
异动快报:嘉应制药(002198)11月6日10点28分触及涨停板
证券之星 · 11-06
异动快报:嘉应制药(002198)11月6日10点28分触及涨停板
嘉应制药(002198)2024年三季报简析:净利润减88.46%
证券之星 · 11-01
嘉应制药(002198)2024年三季报简析:净利润减88.46%
图解嘉应制药三季报:第三季度单季净利润同比减141.97%
证券之星 · 10-31
图解嘉应制药三季报:第三季度单季净利润同比减141.97%
嘉应制药(002198)10月21日主力资金净卖出2055.03万元
证券之星 · 10-22
嘉应制药(002198)10月21日主力资金净卖出2055.03万元
嘉应制药:截止2024年10月18日,根据中登下发的股东名册,公司股东人数为23,183
证券之星 · 10-21
嘉应制药:截止2024年10月18日,根据中登下发的股东名册,公司股东人数为23,183
嘉应制药(002198)10月10日股东户数2.3万户,较上期增加0.91%
证券之星 · 10-17
嘉应制药(002198)10月10日股东户数2.3万户,较上期增加0.91%
嘉应制药最新公告:东方证券计划减持不超过1%公司股份
证券之星 · 10-16
嘉应制药最新公告:东方证券计划减持不超过1%公司股份
嘉应制药(002198.SZ)股东东方证券拟减持不超1%股份
智通财经 · 10-16
嘉应制药(002198.SZ)股东东方证券拟减持不超1%股份
嘉应制药(002198)10月8日主力资金净卖出2758.05万元
证券之星 · 10-09
嘉应制药(002198)10月8日主力资金净卖出2758.05万元
图解嘉应制药中报:第二季度单季净利润同比减91.99%
证券之星 · 08-29
图解嘉应制药中报:第二季度单季净利润同比减91.99%
嘉应制药:8月27日高管李善伟减持股份合计9100股
证券之星 · 08-28
嘉应制药:8月27日高管李善伟减持股份合计9100股
嘉应制药(002198.SZ)发布上半年业绩,净利润566.77万元,下降68.94%
智通财经 · 08-28
嘉应制药(002198.SZ)发布上半年业绩,净利润566.77万元,下降68.94%
嘉应制药(002198)8月26日主力资金净卖出602.13万元
证券之星 · 08-27
嘉应制药(002198)8月26日主力资金净卖出602.13万元
嘉应制药:截止2024年8月9日,根据中登公司下发的股东名册,公司股东人数为22,367
证券之星 · 08-12
嘉应制药:截止2024年8月9日,根据中登公司下发的股东名册,公司股东人数为22,367
公司概况
公司名称:
广东嘉应制药股份有限公司
所属行业:
医药制造业
上市日期:
2007-12-18
主营业务:
广东嘉应制药股份有限公司是一家集研发、生产、销售于一体的专业中药生产企业。公司的主要产品是双料喉风散、双料喉风含片、重感灵片、银翘解毒颗粒、橘红痰咳颗粒、连知解毒胶囊、接骨七厘片、接骨七厘胶囊、疏风活络片、调经活血片、消炎利胆片、金菊五花茶颗粒、壮腰健肾丸、固精参茸丸、桂附理中丸、胃痛片、吐泻肚痛胶囊。公司主导产品双料喉风散、重感灵片曾为国家中药保护品种,且均荣获“广东省名牌产品”称号,具有一定的品牌影响力。2022年金沙药业独家品种接骨七厘片被湖南省药监部门评选为湖南省生物医药产业十大重点产品之一,同时,“中理”商标被国家工商总局评定为中国驰名商标,极大的提升了金沙药业的品牌形象。
发行价格:
5.99
{"stockData":{"symbol":"002198","market":"SZ","secType":"STK","nameCN":"嘉应制药","latestPrice":7.94,"timestamp":1732259004000,"preClose":8.12,"halted":0,"volume":29047261,"delay":0,"floatShares":508000000,"shares":508000000,"eps":0.0243,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.18,"latestTime":"11-22 15:00:00","open":8.13,"high":8.35,"low":7.87,"amount":236000000,"amplitude":0.0591,"askPrice":7.95,"askSize":142,"bidPrice":7.94,"bidSize":37,"shortable":0,"etf":0,"ttmEps":0.0243,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1732498200000},"adr":0,"adjPreClose":8.12,"symbolType":"stock","openAndCloseTimeList":[[1732239000000,1732246200000],[1732251600000,1732258800000]],"highLimit":8.93,"lowLimit":7.31,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":507509848,"pbRate":5.57,"roa":"--","roe":"0.38%","epsLYR":0.0676,"committee":0.281421,"marketValue":4030000000,"floatMarketCap":4030000000,"peRate":326.748975,"changeRate":-0.0222,"turnoverRate":0.0572,"status":1},"requestUrl":"/m/hq/s/002198/wiki","defaultTab":"wiki","newsList":[{"id":"2484645851","title":"嘉应制药(002198)11月8日股东户数2.77万户,较上期增加19.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484645851","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484645851?lang=zh_cn&edition=full","pubTime":"2024-11-18 17:01","pubTimestamp":1731920506,"startTime":"0","endTime":"0","summary":"证券之星消息,近日嘉应制药披露,截至2024年11月8日公司股东户数为2.77万户,较10月18日增加4563.0户,增幅为19.68%。在中药行业个股中,嘉应制药股东户数低于行业平均水平,截至11月8日,中药行业平均股东户数为5.04万户。从股价来看,2024年10月18日至2024年11月8日,嘉应制药区间涨幅为12.13%,在此期间股东户数增加4563.0户,增幅为19.68%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111800021630.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002198","BK0239","BK0077"],"gpt_icon":0},{"id":"2484695396","title":"嘉应制药(002198)11月15日主力资金净买入679.68万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484695396","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484695396?lang=zh_cn&edition=full","pubTime":"2024-11-18 09:13","pubTimestamp":1731892412,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年11月15日收盘,嘉应制药报收于7.71元,上涨2.39%,换手率5.93%,成交量30.1万手,成交额2.32亿元。近5日资金流向一览见下表:嘉应制药融资融券信息显示,融资方面,当日融资买入2153.55万元,融资偿还1747.49万元,融资净买入406.05万元。嘉应制药主营业务:中成药的研发、生产和销售,以治疗喉科、感冒类中成药为主导产品。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111800001995.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002198","BK0239","BK0077"],"gpt_icon":0},{"id":"2483877171","title":"11月14日嘉应制药发布公告,其股东减持507.5万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2483877171","media":"证券之星","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483877171?lang=zh_cn&edition=full","pubTime":"2024-11-14 21:01","pubTimestamp":1731589261,"startTime":"0","endTime":"0","summary":"证券之星消息,11月14日嘉应制药发布公告《嘉应制药:2024-044关于持股5%以上股东股份减持计划实施完成公告》,其股东东方证券股份有限公司于2024年11月13日合计减持507.5万股,占公司目前总股本的1.0%,变动期间该股股价上涨1.06%,截止11月13日收盘报7.65元。股东增减持详情见下表:根据嘉应制药2024年中报公布的十大股东详情如下:以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111400035637.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","002198","BK0239"],"gpt_icon":0},{"id":"2483387456","title":"嘉应制药(002198.SZ)主要股东东方证券完成减持1%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2483387456","media":"智通财经网","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483387456?lang=zh_cn&edition=full","pubTime":"2024-11-14 20:36","pubTimestamp":1731587784,"startTime":"0","endTime":"0","summary":"嘉应制药(002198.SZ)公告,公司持股5%以上股东东方证券累计减持公司股份5...","market":"us","thumbnail":"https://img.zhitongcaijing.com/astock/20.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/astock/20.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1211157.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK0183","BK0012","BK0028","BK0077","BK0239","BK1564","600958","002198","BK1147","BK0276","BK0188","03958"],"gpt_icon":0},{"id":"2483895091","title":"嘉应制药:股东养天和大药房质押约3552.57万股 占公司总股本比例7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483895091","media":"中国财富通","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483895091?lang=zh_cn&edition=full","pubTime":"2024-11-14 10:45","pubTimestamp":1731552334,"startTime":"0","endTime":"0","summary":"中国财富通11月14日 - 嘉应制药(002198)公告称,公司近日收到股东养天和大药房股份有限公司向公司送达的告知函,并通过查阅中国证券登记结算有限责任公司深圳分公司下发文件,获悉其所持有本公司的全部股份办理了质押手续。本次质押股数为35,525,690股,占公司总股本比例7.00%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://irb.cfbond.com/api/v1/detail.html?newsid=I4Hg9JdesQs%3D","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","BK0077","002198"],"gpt_icon":0},{"id":"2483685956","title":"嘉应制药(002198)股东养天和大药房股份有限公司质押3552.57万股,占总股本7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483685956","media":"证券之星","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483685956?lang=zh_cn&edition=full","pubTime":"2024-11-14 03:20","pubTimestamp":1731525649,"startTime":"0","endTime":"0","summary":"证券之星消息,嘉应制药11月14日公开信息显示,股东养天和大药房股份有限公司向长沙农村商业银行股份有限公司金霞支行合计质押3552.57万股,占总股本7.0%。质押详情见下表:截止本公告日,股东养天和大药房股份有限公司已累计质押股份3552.57万股,占其持股总数的100.0%。嘉应制药主营业务:中成药的研发、生产和销售,以治疗喉科、感冒类中成药为主导产品。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111400003539.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002198","BK0077","BK0239"],"gpt_icon":0},{"id":"2481941816","title":"异动快报:嘉应制药(002198)11月6日10点28分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2481941816","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481941816?lang=zh_cn&edition=full","pubTime":"2024-11-06 10:30","pubTimestamp":1730860242,"startTime":"0","endTime":"0","summary":"证券之星11月6日盘中消息,10点28分嘉应制药(002198)触及涨停板。目前价格6.81,上涨10.02%。其所属行业中药目前上涨。领涨股为嘉应制药。该股为养老产业,医药,中药概念热股,当日养老产业概念上涨0.42%,医药概念上涨0.4%,中药概念上涨0.31%。11月5日的资金流向数据方面,主力资金净流出168.42万元,占总成交额2.77%,游资资金净流入74.69万元,占总成交额1.23%,散户资金净流入93.73万元,占总成交额1.54%。近5日资金流向一览见下表:嘉应制药主要指标及行业内排名如下:以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024110600012912.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002198","BK0239","BK0077"],"gpt_icon":0},{"id":"2480993930","title":"嘉应制药(002198)2024年三季报简析:净利润减88.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480993930","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480993930?lang=zh_cn&edition=full","pubTime":"2024-11-01 06:40","pubTimestamp":1730414411,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期嘉应制药发布2024年三季报。根据财报显示,嘉应制药净利润减88.46%。截至本报告期末,公司营业总收入2.6亿元,同比下降31.18%,归母净利润287.33万元,同比下降88.46%。按单季度数据看,第三季度营业总收入7940.31万元,同比下降33.73%,第三季度归母净利润-279.44万元,同比下降141.97%。去年的净利率为6.44%,算上全部成本后,公司产品或服务的附加值一般。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024110100007181.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002198"],"gpt_icon":0},{"id":"2479758553","title":"图解嘉应制药三季报:第三季度单季净利润同比减141.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479758553","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479758553?lang=zh_cn&edition=full","pubTime":"2024-10-31 01:48","pubTimestamp":1730310493,"startTime":"0","endTime":"0","summary":"证券之星消息,嘉应制药2024年三季报显示,公司主营收入2.6亿元,同比下降31.18%;归母净利润287.33万元,同比下降88.46%;扣非净利润-187.9万元,同比下降108.29%;其中2024年第三季度,公司单季度主营收入7940.31万元,同比下降33.73%;单季度归母净利润-279.44万元,同比下降141.97%;单季度扣非净利润-304.17万元,同比下降151.52%;负债率6.98%,投资收益59.08万元,财务费用-115.83万元,毛利率57.42%。财报数据概要请见下图:以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024103100002828.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002198"],"gpt_icon":0},{"id":"2477238198","title":"嘉应制药(002198)10月21日主力资金净卖出2055.03万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477238198","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477238198?lang=zh_cn&edition=full","pubTime":"2024-10-22 09:24","pubTimestamp":1729560295,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年10月21日收盘,嘉应制药报收于6.03元,下跌1.15%,换手率2.23%,成交量11.3万手,成交额6823.35万元。近5日资金流向一览见下表:嘉应制药融资融券信息显示,融资方面,当日融资买入729.42万元,融资偿还1152.14万元,融资净偿还422.72万元。融券方面,融券卖出0.0股,融券偿还0.0股,融券余量8.01万股,融券余额48.3万元。嘉应制药主营业务:中成药的研发、生产和销售,以治疗喉科、感冒类中成药为主导产品。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102200007493.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002198","BK0077"],"gpt_icon":0},{"id":"2477262832","title":"嘉应制药:截止2024年10月18日,根据中登下发的股东名册,公司股东人数为23,183","url":"https://stock-news.laohu8.com/highlight/detail?id=2477262832","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477262832?lang=zh_cn&edition=full","pubTime":"2024-10-21 18:02","pubTimestamp":1729504946,"startTime":"0","endTime":"0","summary":"证券之星消息,嘉应制药(002198)10月21日在投资者关系平台上答复投资者关心的问题。投资者:请问截止2024年10月18日收盘公司股东数是多少?谢谢嘉应制药董秘:尊敬的投资者,您好!截止2024年10月18日,根据中登下发的股东名册,公司股东人数为23,183,感谢您的关注与支持。投资者:请问截止10月18日盘后是多少股东人数?谢谢嘉应制药董秘:尊敬的投资者,您好!截止2024年10月18日,根据中登下发的股东名册,公司股东人数为23,183,感谢您的关注与支持。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102100023959.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002198","BK0077","BK0239"],"gpt_icon":0},{"id":"2476113518","title":"嘉应制药(002198)10月10日股东户数2.3万户,较上期增加0.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=2476113518","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476113518?lang=zh_cn&edition=full","pubTime":"2024-10-17 17:01","pubTimestamp":1729155712,"startTime":"0","endTime":"0","summary":"证券之星消息,近日嘉应制药披露,截至2024年10月10日公司股东户数为2.3万户,较9月30日增加207.0户,增幅为0.91%。在中药行业个股中,嘉应制药股东户数低于行业平均水平,截至10月10日,中药行业平均股东户数为4.94万户。从股价来看,2024年9月30日至2024年10月10日,嘉应制药区间跌幅为6.84%,在此期间股东户数增加207.0户,增幅为0.91%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024101700025141.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002198","BK0077"],"gpt_icon":0},{"id":"2475399311","title":"嘉应制药最新公告:东方证券计划减持不超过1%公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2475399311","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475399311?lang=zh_cn&edition=full","pubTime":"2024-10-16 20:20","pubTimestamp":1729081212,"startTime":"0","endTime":"0","summary":"嘉应制药公告,公司股东东方证券计划自公告之日起十五个交易日后的三个月内以集中竞价交易方式减持公司股份507.51万股(不超过公司总股本比例1%)。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024101600032940.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["03958","BK1564","BK0012","002198","BK0276","BK0188","BK1147","BK0239","BK0077","600958","BK0028","BK0183"],"gpt_icon":0},{"id":"2475998626","title":"嘉应制药(002198.SZ)股东东方证券拟减持不超1%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2475998626","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475998626?lang=zh_cn&edition=full","pubTime":"2024-10-16 20:18","pubTimestamp":1729081096,"startTime":"0","endTime":"0","summary":"智通财经APP讯,嘉应制药(002198.SZ)发布公告,公司股东东方证券现持有公司股份5722.3万股(占公司总股本比例11.28%),其计划自本次减持计划公告之日起十五个交易日后的三个月内以集中竞价交易方式减持公司股份507.51万股(不超过公司总股本比例1%)全部或部分。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1195000.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0183","BK0239","BK0276","BK1564","002198","600958","BK0012","BK1147","BK0028","BK0188","BK0077","03958"],"gpt_icon":0},{"id":"2474237788","title":"嘉应制药(002198)10月8日主力资金净卖出2758.05万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2474237788","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474237788?lang=zh_cn&edition=full","pubTime":"2024-10-09 09:25","pubTimestamp":1728437131,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年10月8日收盘,嘉应制药报收于6.95元,上涨1.16%,换手率5.78%,成交量29.34万手,成交额2.07亿元。近5日资金流向一览见下表:嘉应制药融资融券信息显示,融资方面,当日融资买入3337.91万元,融资偿还1717.35万元,融资净买入1620.56万元,连续3日净买入累计1795.14万元。嘉应制药主营业务:中成药的研发、生产和销售,以治疗喉科、感冒类中成药为主导产品。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024100900005816.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0077","002198"],"gpt_icon":0},{"id":"2463492643","title":"图解嘉应制药中报:第二季度单季净利润同比减91.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2463492643","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2463492643?lang=zh_cn&edition=full","pubTime":"2024-08-29 01:48","pubTimestamp":1724867314,"startTime":"0","endTime":"0","summary":"证券之星消息,嘉应制药2024年中报显示,公司主营收入1.8亿元,同比下降30.0%;归母净利润566.77万元,同比下降68.94%;扣非净利润116.26万元,同比下降93.07%;其中2024年第二季度,公司单季度主营收入8578.62万元,同比下降33.46%;单季度归母净利润48.56万元,同比下降91.99%;单季度扣非净利润-263.18万元,同比下降145.76%;负债率8.92%,投资收益98.89万元,财务费用-84.15万元,毛利率56.23%。财报数据概要请见下图: 以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024082900002264.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002198"],"gpt_icon":0},{"id":"2462450756","title":"嘉应制药:8月27日高管李善伟减持股份合计9100股","url":"https://stock-news.laohu8.com/highlight/detail?id=2462450756","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462450756?lang=zh_cn&edition=full","pubTime":"2024-08-28 21:01","pubTimestamp":1724850099,"startTime":"0","endTime":"0","summary":"证券之星消息,根据8月28日市场公开信息、上市公司公告及交易所披露数据整理,嘉应制药(002198)最新董监高及相关人员股份变动情况:2024年8月27日公司独立董事李善伟共减持公司股份9100.0股,占公司总股本为0.0018%。变动期间公司股价上涨1.16%,8月27日当日收盘报6.08元。嘉应制药近半年内的董监高及核心技术人员增减持详情如下:嘉应制药的高管列表及最新持股情况如下:融资融券数据显示该股近5日融资净流出37.77万,融资余额减少;融券净流入3.36万,融券余额增加。该股最近90天内无机构评级。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024082800041500.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002198","BK0239","BK0077"],"gpt_icon":0},{"id":"2462596324","title":"嘉应制药(002198.SZ)发布上半年业绩,净利润566.77万元,下降68.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2462596324","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462596324?lang=zh_cn&edition=full","pubTime":"2024-08-28 19:42","pubTimestamp":1724845345,"startTime":"0","endTime":"0","summary":"智通财经APP讯,嘉应制药(002198.SZ)发布2024年半年度报告,报告期内,公司实现营业收入1.8亿元,同比下降30.00%。实现归属于上市公司股东的净利润566.77万元,同比下降68.94%。实现归属于上市公司股东的扣除非经常性损益的净利润116.26万元,同比下降93.07%。基本每股收益0.0112元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1173572.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["002198"],"gpt_icon":0},{"id":"2462908994","title":"嘉应制药(002198)8月26日主力资金净卖出602.13万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2462908994","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462908994?lang=zh_cn&edition=full","pubTime":"2024-08-27 09:20","pubTimestamp":1724721640,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年8月26日收盘,嘉应制药报收于6.01元,下跌3.22%,换手率0.77%,成交量3.9万手,成交额2378.35万元。近5日资金流向一览见下表:嘉应制药融资融券信息显示,融资方面,当日融资买入304.69万元,融资偿还292.86万元,融资净买入11.84万元,连续3日净买入累计72.04万元。嘉应制药主营业务:中成药的研发、生产和销售,以治疗喉科、感冒类中成药为主导产品。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024082700008216.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002198","BK0077"],"gpt_icon":0},{"id":"2458173982","title":"嘉应制药:截止2024年8月9日,根据中登公司下发的股东名册,公司股东人数为22,367","url":"https://stock-news.laohu8.com/highlight/detail?id=2458173982","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458173982?lang=zh_cn&edition=full","pubTime":"2024-08-12 23:00","pubTimestamp":1723474836,"startTime":"0","endTime":"0","summary":"证券之星消息,嘉应制药(002198)08月12日在投资者关系平台上答复投资者关心的问题。投资者:请问截止8月9日收盘公司在册股东人数多少?谢谢!嘉应制药董秘:尊敬的投资者,您好!截止2024年8月9日,根据中登公司下发的股东名册,公司股东人数为22,367,感谢您的关注与支持。以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024081200033656.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002198","BK0239","BK0077"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2007-12-18","address":"广东省梅州市梅江区东升工业园B区","stockEarnings":[{"period":"1week","weight":0.0298},{"period":"1month","weight":0.2848},{"period":"3month","weight":0.2786},{"period":"6month","weight":0.2416},{"period":"1year","weight":0.0549},{"period":"ytd","weight":0.0984}],"companyName":"广东嘉应制药股份有限公司","boardCode":"AI0027","perCapita":"18291股","boardName":"医药制造业","registeredCapital":"50750万元","compareEarnings":[{"period":"1week","weight":-0.0191},{"period":"1month","weight":-0.0108},{"period":"3month","weight":0.1446},{"period":"6month","weight":0.0577},{"period":"1year","weight":0.0671},{"period":"ytd","weight":0.0982}],"survey":" 广东嘉应制药股份有限公司是一家集研发、生产、销售于一体的专业中药生产企业。公司的主要产品是双料喉风散、双料喉风含片、重感灵片、银翘解毒颗粒、橘红痰咳颗粒、连知解毒胶囊、接骨七厘片、接骨七厘胶囊、疏风活络片、调经活血片、消炎利胆片、金菊五花茶颗粒、壮腰健肾丸、固精参茸丸、桂附理中丸、胃痛片、吐泻肚痛胶囊。公司主导产品双料喉风散、重感灵片曾为国家中药保护品种,且均荣获“广东省名牌产品”称号,具有一定的品牌影响力。2022年金沙药业独家品种接骨七厘片被湖南省药监部门评选为湖南省生物医药产业十大重点产品之一,同时,“中理”商标被国家工商总局评定为中国驰名商标,极大的提升了金沙药业的品牌形象。","serverTime":1732372744135,"listedPrice":5.99,"stockholders":"27746人(较上一季度增加19.68%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"嘉应制药(002198)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供嘉应制药(002198)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"嘉应制药,002198,嘉应制药股票,嘉应制药股票老虎,嘉应制药股票老虎国际,嘉应制药行情,嘉应制药股票行情,嘉应制药股价,嘉应制药股市,嘉应制药股票价格,嘉应制药股票交易,嘉应制药股票购买,嘉应制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"嘉应制药(002198)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供嘉应制药(002198)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}